News
The equal pay activist Lilly Ledbetter made headlines in 2007 when she sued her employer, Goodyear Tire and Rubber Company, for gender discrimination, resulting in a Supreme Court case and ...
Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.. The ...
‘Lilly’ Review: Equal-Pay Activist and Trailblazer Lilly Ledbetter Deserves a Much Better Film Reviewed online, Jan. 2, 2025. In Palms Springs Film Festival.
Eli Lilly isn't done in developing new weight loss treatments. In fact, the best may still be to come, as it's working on a pill, which could be a game changer for the industry.
Now, a new film, "Lilly," starring Patricia Clarkson, chronicles Ledbetter's David-and-Goliath-type fight for equal pay against her employer, Goodyear Tire and Rubber Company, in Alabama.
Eli Lilly (LLY 0.34%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical wins, the company may even be taking the lead ahead of ...
Pharmaceutical company Eli Lilly warning in an open letter on Thursday about the dangers of fake and compounded versions of its diabetes and weight loss medications Mounjaro and Zepbound.
Here’s what to know about Eli Lilly’s pill, which still must go through a review process by the Food and Drug Administration to be approved for sale. When will the pill become available?
Eli Lilly's new weight loss drug is "transformational," obesity doctor says 02:33. Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results